Satyan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 38 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.04 Cr
as on 15-11-2024
- Revenue -50.15%
(FY 2023)
- Profit -130.74%
(FY 2023)
- Ebitda -165.92%
(FY 2023)
- Net Worth -7.38%
(FY 2023)
- Total Assets -8.35%
(FY 2023)
About Satyan Pharmaceuticals
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.04 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Yash Sanghavi, Bhavna Sanghavi, Satyen Sanghavi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1986PTC041306
- Company No.
041306
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Satyan Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Sanghavi  | Managing Director | 21-Oct-1986 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyen Sanghavi | Director | 02-May-2008 | Current |
| Bhavna Sanghavi | Director | 21-Oct-1986 | Current |
| Vasant Mhatre | Director | 25-Mar-2009 | Current |
Financial Performance of Satyan Pharmaceuticals.
Satyan Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.15% decrease. The company also saw a substantial fall in profitability, with a 130.74% decrease in profit. The company's net worth dipped by a decrease of 7.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satyan Pharmaceuticals?
In 2023, Satyan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Regrow Biosciences Private LimitedActive 35 years 1 monthYash Sanghavi, Bhavna Sanghavi and 1 more are mutual person
- Regrow Therapeutics Private LimitedActive 7 years 3 months
Yash Sanghavi and Satyen Sanghavi are mutual person
Biocord Lifescience Private LimitedActive 6 years 11 monthsYash Sanghavi and Satyen Sanghavi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
3I Infotech Trusteeship Services Limited Creation Date: 09 Aug 2007 | ₹1.90 Cr | Satisfied |
New Indi Aco-Op Bank Ltd Creation Date: 12 Oct 2000 | ₹0.87 M | Satisfied |
New Indi Aco-Op Bank Ltd Creation Date: 04 Jun 1998 | ₹0.48 M | Satisfied |
How Many Employees Work at Satyan Pharmaceuticals?
Unlock and access historical data on people associated with Satyan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
